Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 05-2010 | 02-2010 | 11-2009 | 08-2009 | 05-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10 | 1 | 4 | 1 | 10 |
| Other current assets | 10 | 9 | 16 | 9 | 30 |
| TOTAL | $20 | $10 | $20 | $10 | $40 |
| Non-Current Assets | |||||
| PPE Net | 20 | 20 | 20 | 20 | 20 |
| Investments And Advances | 4 | 3 | 3 | 3 | 3 |
| Other Non-Current Assets | 0 | 0 | 0 | 4 | 30 |
| TOTAL | $24 | $23 | $23 | $27 | $53 |
| Total Assets | $30 | $20 | $30 | $20 | $80 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 130 | 140 | 160 | 260 | 240 |
| Accrued Expenses | 30 | 30 | 20 | 100 | 80 |
| Other current liabilities | 0 | 0 | 0 | 2 | 2 |
| TOTAL | $260 | $270 | $280 | $1,470 | $1,730 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 360 | 360 | 360 | 360 | 0 |
| TOTAL | $360 | $360 | $360 | $360 | $N/A |
| Total Liabilities | $620 | $630 | $650 | $1,830 | $1,730 |
| Shareholders' Equity | |||||
| Common Shares | 180 | 180 | 180 | 150 | 120 |
| Retained earnings | -57,640 | -57,580 | -57,490 | -57,070 | -56,860 |
| Other shareholders' equity | 10 | 40 | 40 | 10 | 1,560 |
| TOTAL | $-590 | $-610 | $-610 | $-1,810 | $-1,640 |
| Total Liabilities And Equity | $30 | $20 | $40 | $20 | $90 |